Moreover, higher levels of Th2 cytokines—IL-10 [14] and IL-5 [3]—were related to the lack of pathologic complete response after chemotherapy and worse survival in breast cancer patients, respectively. This evidence concerns the gene IL5 and breast carcinoma.